Skip to main content
FDA panel voices concerns over 2 lymphoma accelerated approvals
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
FDA panel voices concerns over 2 lymphoma accelerated approvals
User login
Username
Password
Reset your password
Concept
Lead
score
Patient Safety
1
1
Lymphoma
0
0.7
Cancer
0
0.53
Grant
0
0.44
Adverse Effects
0
0.09
Hospital
0
0.09
Ohio
0
0.09
Oregon
0
0.09
Refractory
0
0.09
Specialty
Lead
score
Hematology-Oncology
1
1
Pharmacist
0
0.9
Edit Tags